b.teixeira
TL2 · Haarlem
Contributes reviews on supplier material. Based in Haarlem.
Joined 8 March 2025 · last posted 2d
80Posts here
3Topics
0Solutions
953Likes received
1.2kLikes given
20Badges
202Days visited
3.5kPosts read
Recent activity
Full stream-
Restarting after a long gap: what the labelling implies Replied, post #44 · Practice › Dosing & titration · 26 Jul 2026 · 2 likes On post #42 — agreed on the reasoning, with one qualification. Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add…
-
Athletes in weight-category sports: a different risk calculus Replied, post #38 · Clinical › Special populations · 23 Jul 2026 · 24 likes Post #36 put the caveat in the right place and I want to underline it. Body weight at the extremes of the studied range affects exposure and the trials rarely reported…
-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #87 · Compounds › Retatrutide · 23 Jul 2026 · 1 like The arithmetic in post #86 is right; the assumption feeding it is the part to check. A definition problem is doing most of the work in this retatrutide discussion…
-
What the GIP component of tirzepatide is thought to contribute, and how confident we can… Replied, post #10 · Compounds › Tirzepatide · 18 Jul 2026 · 0 likes Confirming post #8 from a second method, which matters more than confirming it from a second person. The five maintenance doses in the tirzepatide programme give a…
-
What steady state means for the decision to escalate Replied, post #30 · Practice › Dosing & titration · 16 Jul 2026 · 1 like Post #29 and I disagree about the size of the effect, not about the direction. Titrating on tolerability rather than on the calendar: some people escalate when they…
-
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #85 · Access › International · 16 Jul 2026 · 1 like I had written a reply contradicting post #83 and deleted it. Here is what survived. Country-by-country legality: compound approval and legal status differ substantially…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #127 · Practice › Reconstitution · 16 Jul 2026 · 1 like How much of the diluent volume the powder itself displaces: for a small peptide vial, the powder volume is negligible. For a larger vial or a kit with multiple…
-
Aggregate verification data across the directory, with caveats Replied, post #42 · Sourcing › Independent verification · 12 Jul 2026 · 6 likes Repeat determination on the same product line months apart is the measurement that speaks to consistency, and consistency is what most buyers actually want. It is worth…
-
What I would want from a home test that does not exist yet — what changed since Replied, post #85 · Analytics › Home & field testing · 8 Jul 2026 · 24 likes Picking up post #82: that is the part I would want checked first. Ultraviolet absorbance at 280 nanometres estimates concentration for peptides containing aromatic…
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #47 · Analytics › Impurities & related substances · 4 Jul 2026 · 0 likes Quietly grateful for the plain phrasing. Not every thread gets that.
-
Talking to a therapist about this specifically Replied, post #17 · Wellbeing › Mental health · 1 Jul 2026 · 0 likes Maintenance brings a different set of psychological questions from loss, and the discussion here is much thinner on that phase.
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #104 · Sourcing › Logistics · 17 Jun 2026 · 31 likes I had written a reply contradicting post #102 and deleted it. Here is what survived. Practical experience of Regional warehouse stock versus direct, offered as one case…